Consensus guidelines from the American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States

Annals of Surgical Oncology

Volumn 21, Issue 5, 2014, Pages 1501-1505

  Turaga, K ^a   Levine, E ^b   Barone, R ^c   Sticca, R ^d   Petrelli, N ^e   Lambert, L ^f   Nash, G ^g   Morse, M ^h   Adbel Misih, R ^e   Alexander, H R ⁱ   Attiyeh, F ^j   Bartlett, D ^k   Bastidas, A ^l   Blazer, T ^h   Chu, Q ^m   Chung, K ^g   Dominguez Parra, L ⁿ   Espat, N J ^o   Foster, J ^p   Fournier, K ^q   Garcia, R ^r   Goodman, M ^s   Hanna, N ⁱ   Harrison, L ^t   Hoefer, R ^u   Holtzman, M ^k   Kane, J ^v   Labow, D ^w   Li, B ^m   Lowy, A ^x   Mansfield, P ^q   Ong, E ^y   Pameijer, C ^z   Pingpank, J ^aa   Quinones, M ^ab   Royal, R ^q   Salti, G ^ac   Sardi, A ^ad   Shen, P ^b   Skitzki, J ^v   Spellman, J ^ae   Stewart, J ^b   Esquivel, J ^af   more..

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b WAKE FOREST UNIVERSITY   (United States)

^c Sharp Health System   (United States)

^d UNIVERSITY OF NORTH DAKOTA   (United States)

^e CHRISTIANA CARE HEALTH SYSTEM   (United States)

^f UMASS MEMORIAL MEDICAL CENTER   (United States)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h DUKE UNIVERSITY   (United States)

ⁱ UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^j ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^k UNIVERSITY OF PITTSBURGH   (United States)

^l National Surgical Assocs   (United States)

^m LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

ⁿ Infectious Diseases Research Unit Hospital Regional de Alta Especialidad de la Península de Yucatán   (Mexico)

^o ROGER WILLIAMS MEDICAL CENTER   (United States)

^p UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^q UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^r HOSPITAL REGIONAL DE ALTA ESPECIALIDAD DE OAXACA   (Mexico)

^s Tuffs Medical School   (United States)

^t RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^u Sentara Surgical Assocs   (United States)

^v ROSWELL PARK CANCER INSTITUTE   (United States)

^w MOUNT SINAI MEDICAL CENTER   (United States)

^x UNIVERSITY OF CALIFORNIA   (United States)

^y UNIVERSITY OF ARIZONA   (United States)

^z STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^aa UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^ab DeKalb Medical Center   (United States)

^ac UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^ad MERCY MEDICAL CENTER   (United States)

^ae Beebe Medical Center   (United States)

^af ST AGNES HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMERICAN SOCIETY OF PERITONEAL SURFACE MALIGNANCIES; ARTICLE; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER PATIENT; CARCINOMATOSIS; COLORECTAL CANCER; CYTOREDUCTIVE SURGERY; DRUG DELIVERY SYSTEM; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; PERITONEUM METASTASIS; POPULATION RESEARCH; PRACTICE GUIDELINE; UNITED STATES; COLORECTAL NEOPLASMS; CONSENSUS; HEALTH CARE ORGANIZATION; HYPERTHERMIC THERAPY; MULTIMODALITY CANCER THERAPY; PERITONEAL NEOPLASMS; REGIONAL PERFUSION; STANDARDS;

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; CONSENSUS; HUMANS; HYPERTHERMIA, INDUCED; PERITONEAL NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, SCIENTIFIC;

EID: 84898852205     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-3061-z     Document Type: Article

References (7)

1. Spratt J, Adcock R, Muskovin M, Sherrill W, McKeown J. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res. 1980;40:256-260. (Pubitemid 10140145)
2. Esquivel J. Technology of hyperthermic intraperitoneal chemotherapy in the United States, Europe, China, Japan and Korea. Cancer J. 2009;15:249-254.
3. Esquivel J, Stojadinovic A, Levine E. The American Society of Peritoneal Surface Malignancies. Ann Surg Oncol. 2011;18:S218-S219.
4. Elias D, Lefevre J, Chevalier J, Brouquet A, Marchal F, Classe JM, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with Oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009;27:681-685.
5. Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737-3743. (Pubitemid 46606227)
6. Klaver YL, Hendriks T, Lomme RM, Rutten HJ, Bleichrodt RP, de Hingh IH. Hyperthermia and intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis: An experimental study. Ann Surg. 2011;254:125-130.
7. Yonemura Y, Elnemr A, Endou Y, Hirano M, Mizumoto A, Takao N, et al. Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer. World J Gastrointest Oncol. 2010;2:85-97.